Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
CSPC Pharmaceutical Group Limited (CHJTF)
OTHER OTC:CHJTF
RESEARCH TOOLSreports
Holding CHJTF?
Track your performance easily
CHJTF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.44 - $0.97
Previous Close$0.67
Volume38.00K
Average Volume (3M)13.85K
Market Cap
$7.79B
Enterprise Value$6.22B
Total Cash (Recent Filing)¥13.41B
Total Debt (Recent Filing)¥682.56M
Price to Earnings (P/E)9.7
Beta0.89
Next Earnings
Mar 19, 2025EPS Estimate
$0.02Last Dividend Ex-Date
Oct 31, 2024Dividend Yield5.77%
Share Statistics
EPS (TTM)0.07
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume13,846
Standard Deviation0.14
R-Squared0.00050
Alpha0.00976
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)2.85
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$0.99Price Target Upside47.76% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
CSPC Pharmaceutical Group News
PremiumCompany Announcements
CSPC Pharmaceutical Group Reports Decline in Nine-Month Earnings
PremiumCompany Announcements
CSPC Pharmaceutical Sees Revenue and Profit Decline in 2024
PremiumCompany Announcements
CSPC Pharmaceutical Gains Approval for HPV Vaccine TrialsPremiumCompany Announcements
CSPC Pharmaceutical Group to Announce Financial Results
PremiumCompany Announcements
CSPC Pharmaceutical Warns of Profit Decline Amid Drug Sales Challenges
PremiumCompany Announcements
CSPC Pharma Advances CAR-T Therapy for Myasthenia Gravis
PremiumCompany Announcements
CSPC Innovation Reports Declining Financial PerformanceBulls Say, Bears Say
Bulls Say
Dividends And BuybacksShare price correction has increased the dividend yield to approximately 6%, and an incremental share buyback is likely to ease selling pressure.
Financial PerformanceGross profit margin improved to 71.6% due to a higher proportion of revenue from finished drugs.
Growth PotentialInvestors are expected to shift focus to new product sales ramp-up, projected to have a 52% compound annual growth rate.
Bears Say
Earnings RiskFuture earnings are at risk due to ongoing anti-corruption measures and price cuts in major products, which continue to exert downward pressure.
Financial Performance2Q24 revenue and underlying profit were more than 10% below market expectations, primarily due to weak sales in the oncology sector.
Product SalesSales targets for new products have been lowered because of delays in getting them listed in hospitals.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
3.55% Mutual Funds
― Other Institutional Investors
89.77% Public Companies and
Individual Investors
CHJTF FAQ
What was CSPC Pharmaceutical Group Limited’s price range in the past 12 months?
CSPC Pharmaceutical Group Limited lowest stock price was $0.44 and its highest was $0.97 in the past 12 months.
What is CSPC Pharmaceutical Group Limited’s market cap?
Currently, no data Available
When is CSPC Pharmaceutical Group Limited’s upcoming earnings report date?
CSPC Pharmaceutical Group Limited’s upcoming earnings report date is Mar 19, 2025 which is in 116 days.
How were CSPC Pharmaceutical Group Limited’s earnings last quarter?
CSPC Pharmaceutical Group Limited released its earnings results on Nov 15, 2024. The company reported $0.009 earnings per share for the quarter, missing the consensus estimate of $0.014 by -$0.006.
Is CSPC Pharmaceutical Group Limited overvalued?
According to Wall Street analysts CSPC Pharmaceutical Group Limited’s price is currently Undervalued.
Does CSPC Pharmaceutical Group Limited pay dividends?
CSPC Pharmaceutical Group Limited pays a Annually dividend of $0.02 which represents an annual dividend yield of 5.77%. See more information on CSPC Pharmaceutical Group Limited dividends here
What is CSPC Pharmaceutical Group Limited’s EPS estimate?
CSPC Pharmaceutical Group Limited’s EPS estimate is $0.02.
How many shares outstanding does CSPC Pharmaceutical Group Limited have?
CSPC Pharmaceutical Group Limited has 11,695,882,000 shares outstanding.
What happened to CSPC Pharmaceutical Group Limited’s price movement after its last earnings report?
CSPC Pharmaceutical Group Limited reported an EPS of $0.009 in its last earnings report, missing expectations of $0.014. Following the earnings report the stock price went down -1.493%.
Which hedge fund is a major shareholder of CSPC Pharmaceutical Group Limited?
Currently, no hedge funds are holding shares in CHJTF
---
CSPC Pharmaceutical Group Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$0.99 (47.76% Upside)
$0.99 (47.76% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.03%
12-Months-Change
Fundamentals
Return on Equity
17.87%
Trailing 12-Months
Asset Growth
9.64%
Trailing 12-Months
Company Description
CSPC Pharmaceutical Group Limited
CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. It operates through the following business segments: Finished Drugs, Antibiotics, Vitamin C, Caffeine and Others. The company was founded on August 21, 1997 and is headquartered in Hong Kong.
---
CHJTF Stock 12 Month Forecast
Average Price Target
$0.99
▲(47.76% Upside)
Technical Analysis
Best Analysts Covering CHJTF
1 Year
1 Year Success Rate
2/6 ratings generated profit
1 Year Average Return
-12.47%
reiterated a buy rating 3 months ago
Copying Jill Wu's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -12.47% per trade.
---